Back | Next |
home / stock / gdrx / gdrx message board
Subject | By | Source | When |
---|---|---|---|
Time for a bounce? | jablome | investorshub | 06/18/2023 8:12:19 AM |
The trading | jablome | investorshub | 06/18/2023 2:38:34 AM |
$GDRX Found an interesting article | crudeoil24 | investorshub | 06/17/2023 4:02:17 AM |
we got news | TREND1 | investorshub | 06/15/2023 8:10:10 AM |
$GDRX The gaining up | crudeoil24 | investorshub | 06/13/2023 12:56:53 PM |
Lets go go go go... Up up and away we go. | @LaughinPaulRyan | investorshub | 06/12/2023 2:15:50 PM |
2k at 6.37 | jablome | investorshub | 08/18/2022 1:37:58 PM |
GoodRx (NASDAQ:GDRX) was downgraded by analysts at Royal | conix | investorshub | 05/10/2022 4:04:38 PM |
... $JPM Sees Doom And Gloom in $GDRX ... | @LaughinPaulRyan | investorshub | 11/23/2020 5:42:26 AM |
GoodRx lists virtually all FDA-approved prescription medications, including | @LaughinPaulRyan | investorshub | 11/20/2020 6:23:24 PM |
... TRUMP $GDRX BOOM ... #LOOTWALLSTREET | @LaughinPaulRyan | investorshub | 11/20/2020 5:36:42 PM |
... WE GOOD HERE ... $GDRX | @LaughinPaulRyan | investorshub | 11/19/2020 11:44:46 PM |
... GOODRX OVER AMAZON PHARMACY ... $GDRX | @LaughinPaulRyan | investorshub | 11/19/2020 6:41:04 PM |
... SO 54% JIM CRAMER $GDRX JUMP COMING ... | @LaughinPaulRyan | investorshub | 11/19/2020 5:11:43 PM |
ok folks i cant hold her back anymore | jablome | investorshub | 11/19/2020 3:09:46 PM |
shhh someone might hear you.. | jablome | investorshub | 11/19/2020 2:54:49 PM |
how low can she go, lets see | jablome | investorshub | 11/18/2020 1:00:38 PM |
$AMZN strikes fear everywhere it shows up. | conix | investorshub | 11/17/2020 11:37:17 PM |
i can already tell this one is going | jablome | investorshub | 11/17/2020 10:03:58 PM |
+500shares at 35.72 | jablome | investorshub | 11/17/2020 9:35:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Consumers have paid $21 billion out-of-pocket on prescription medications in 2024, an average of $16.26 per prescription Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-po...
2024-06-10 07:00:04 ET Craig Hettenbach from Morgan Stanley issued a price target of $9.50 for GDRX on 2024-06-10 05:32:00. The adjusted price target was set to $9.50. At the time of the announcement, GDRX was trading at $8.55. The overall price target consensus is at $1...
2024-05-31 07:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...